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ABSTRACT
Objectives: Unipolar depression (UPD) is a leading cause of global burden of diseases, par-
ticularly among the elderly, whose treatment may be challenging. In such cases, ECT is often 
recommended due to its safety and efficacy. This report presents a case of a 67-year-old male 
inpatient that developed a rare cardiac complication during ECT. Methods: Clinical case re-
port with patient’s consent and bibliographic review. Results: A 67-year-old male inpatient 
with recurrent severe psychotic depression was hospitalized and ECT was indicated after fai-
lure of the pharmacological treatment. A comprehensive clinical pre-evaluation revealed only 
nonspecific ST-segment changes in electrocardiogram. During the 7th ECT session, it was 
observed transitory ST-segment depression followed by a discrete increase of plasma tropo-
nin I. Severe tri-vessel coronary artery stenosis was found and a percutaneous coronary an-
gioplasty was performed, with satisfactory psychiatric and cardiac outcomes. Conclusions: 
Unipolar depression (UPD) and cardiovascular disease are often coexistent conditions, espe-
cially among the elderly. In the current case, myocardial ischemia was detected lately during 
ECT therapy and its treatment allowed the UPD treatment to be completed adequately.
RESUMO
Objetivos: Depressão unipolar é uma das principais causas de sobrecarga global de doen-
ças, particularmente entre os idosos, cujo tratamento pode ser desafiador. Nesses casos, a 
eletroconvulsoterapia (ECT) é frequentemente indicada, por causa de sua segurança e efi-
cácia. Este relato apresenta o caso de um paciente de 67 anos internado e que desenvolveu 
uma complicação cardíaca rara após ECT. Métodos: Relato de caso clínico e revisão da lite-
ratura. Resultados: Um homem de 67 anos com transtorno depressivo grave, com sinto-
mas psicóticos recorrentes, foi hospitalizado, sendo indicada ECT após falha do tratamento 
farmacológico. Foi realizada uma pré-avaliação clínica, a qual revelou alterações não especí-
ficas do segmento ST ao eletrocardiograma. Durante a sétima sessão de ECT, foi observada 
depressão transitória do segmento ST seguida por discreto aumento da troponina I sérica. 
Foi diagnosticada estenose coronária triarterial, sendo realizada angioplastia coronária per-
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cutânea, com boa evolução clínica e psiquiátrica. Conclusões: Depressão unipolar e doença 
cardiovascular são condições que coexistem com frequência, especialmente entre os idosos. 
No presente relato, isquemia miocárdica foi detectada tardiamente durante a ECT e a sua 
correção permitiu que a depressão unipolar fosse tratada adequadamente. 
Palavras-chave
Eletroconvulsoterapia, 
transtorno depressivo 
maior, angina instável, 
estenose coronária, idoso.
INTRODUCTION
Severe unipolar depression (UPD) is a leading cause of global 
burden of diseases, particularly among the elderly1,2, whose 
treatment may be challenging due to antidepressants’ car-
diovascular side effects and poor therapeutic response1. In 
such cases, electroconvulsive therapy (ECT) is highly recom-
mended, considering its safety and high rates of efficacy3. 
Studies reported that the immediate efficacy rate is even 
higher in elderly diagnosed with severe mood disorders4-6 
and the mortality associated with the procedure is low: 
1-2/100.000 treatments7. ECT’s adverse effects include blood 
pressure elevation and bradycardia after electric stimulation, 
besides tachycardia with elevation of myocardial demand 
during convulsion2. Most hemodynamic changes persist into 
the recovery period and resolve within 20 minutes2. Patients 
who have previous cardiac disease present higher risk of car-
diac complications after the procedure2,6,8. Nevertheless, the 
majority of patients conclude their ECT sessions safely, even 
those who present cardiac complications afterwards4-10.
The aim of this report is to describe a situation in which 
even nonspecific findings in a patients’ electrocardiogram 
may justify the need for a thorough cardiologic assessment 
before the ECT sessions, in order to avoid further complica-
tions.
METHODS
A bibliographic research was made through the National 
Center for Biotechnology Information (NCBI/PubMed) and 
Scopus websites. Review articles and case reports were used 
as a basis for the discussion, fostered by the clinical and 
psychiatric patient’s condition described below. After the 
patient’s written consent, a descriptive report was made ba-
sed on clinical interview and chart review. 
RESULTS
A 67 year-old male who had hypertension, benign prosta-
tic hyperplasia and chronic renal failure stage III was diag-
nosed with severe UPD in 2008, which was associated with 
delusions of ruin, anorexia (66 pounds of weight loss in three 
months), suicidal ideation and serious personal and socioe-
conomic dysfunction. It remitted only after 10 ECT sessions, 
carried out during hospitalization. Later on, his maintenance 
treatment has failed, despite the combined use of several 
antidepressants and antipsychotics in high doses, such as 
olanzapine 20 mg/day combined with mirtazapine 45 mg/
day, then with venlafaxine 150 mg/day and later with mir-
tazapine 60 mg/day; sertraline 150 mg/day associated with 
amitriptyline 75 mg/day; citalopram 20 mg/day and finally 
aripiprazole 30 mg/day associated with sertraline 150 mg/
day. He made two suicide attempts with medication and 
was hospitalized several times in the following years.
In 2013, he was admitted to the psychiatric emergency 
unit due to inanition, with malnutrition, dehydration lead-
ing to acute renal failure and severe depressive symptoms, 
such as those presented in 2008, which were refractory to 
150 mg/day of sertraline; his initial Montgomery-Åsberg 
Depression Rating Scale (MADRS) score was 36 (mild: 9-17, 
moderate: 18-34, severe ≥ 35). He was then hospitalized in 
the general hospital psychiatric impatient ward and had no 
improvement after an increase in the dose of sertraline to 
200 mg/day. ECT was again indicated, besides the antide-
pressant, with the consent of both the patient and his family.
He was evaluated by the cardiology team with clinical 
examination, laboratory tests, chest X-ray and electrocar-
diogram (EKG). EKG showed repolarization abnormalities in 
inferior and anterior leads and signs of left ventricular (LV) 
overload. Serum dosages were: sodium = 140 mg/dL; po-
tassium = 4.3 mg/dL; magnesium = 0.94 mg/dL; urea = 42 mg/
dL; creatinine = 1.57 mg/dL; fasting glycemia = 94 mg/dL; 
TSH = 3.76 mg/dL; thyroxine = 0.84 mg/dL; hemoglobin = 
13.2 g/dL (6% of glycated hemoglobin); hematocrit = 38.8%; 
leukocytes = 8,690/mL; platelets = 227,000/mL. As the car-
diologists in charge did not indicate any further measures 
for reducing cardiovascular risks related to the procedure, 
the patient was referred to anesthetic evaluation and ECT. 
Bilateral ECT was performed with standard anesthesia and 
bi-temporal placement of electrodes, using a Thymatron 
device (Somatics Inc.). ECT sessions were held three times a 
week and the seizures were verified through the “Tourniquet 
Technique”.
Great clinical and psychiatric improvements were already 
observed by the seventh ECT session, with increased psycho-
motricity and MADRS score of 14. In this occasion, given a first 
trial failure, it was applied a 70% potentiation, which produced 
a 30 seconds seizure. After nearly 2 minutes, it was witnessed 
a ST segment depression on lead II EKG’s monitor. A couple 
of hours later, the patient presented lipothymia, followed 
by hypotension and low cardiac output transient symptoms, 
without any EKG changes. The episode was considered an 
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angina equivalent and acute coronary syndrome’s evaluation 
was initiated: cardiac enzymes showed discrete elevation, 
nonspecific for myocardial infarction. The echocardiogram 
revealed: LV segmental wall abnormality; preserved systolic 
function, with ejection fraction (Simpson) > 50%; LV diastolic 
dysfunction and hypertrophy; thickened mitral, aortic and tri-
cuspid valves. The scintigraphy (I-131 MIBG) showed: wide and 
accentuated hypoperfusion of apex and mid-apical’s portion 
of LV’s septal, inferoseptal and inferior walls; mild ischemic 
component and ejection fraction of 52%. Afterwards, the car-
diologists indicated cardiac catheterization, which revealed: 
severe coronary tri-arterial obstruction, affecting left anterior 
descendent artery (left ADA) and right coronary artery (80% of 
obstruction); circumflex artery and second marginal branch 
(70% and 60% of obstruction, respectively).
After the seventh session, ECT was suspended and ser-
traline, 200 mg/day, was maintained. Although coronary ar-
tery bypass grafting was considered the standard treatment 
to this patient, it was decided to perform percutaneous 
coronary angioplasty of ADA after multidisciplinary meeting 
and patient’s family consent, considering the surgical risk 
(EuroSCORE = 10.33%) and his impaired nutritional status. He 
had an excellent cardiologic outcome and is clinically well.
DISCUSSION
This patient was diagnosed with severe UPD disorder, with 
poor response to pharmacological treatment and excellent 
previous response to ECT. The psychiatric disorder led to a 
clinical deterioration that evolved to a potentially life-thre-
atening condition. Probably due to his limited myocardial 
demand, related to physical and psychiatric impairment, 
he was not aware of any personal history of cardiovascular 
disease, although having a previous tri-vessel severe and 
asymptomatic stenosis. The elevation of myocardial demand 
during ECT sessions probably caused an unstable angina 
episode, which is a rare complication after this procedure. 
Nevertheless, the patient had previously completed se-
ven ECT sessions and had a great treatment response (his 
MADRS’ score decreased more than 50%).
There is a rising prevalence of UPD in the elderly, com-
monly with poor therapeutic response to pharmacological 
treatment1,2. Also, as antidepressants and other drugs used in 
old-age psychiatry have potentially severe adverse effects3, 
ECT becomes an important treatment option. Although car-
diac complications are rare3, the situation described in this 
case report countersigns that even nonspecific findings in 
the electrocardiogram may justify the need for a thorough 
cardiologic assessment before the ECT sessions, in order to 
assure their safety and efficacy. 
Deaths due to coronary accidents during or following 
ECT have been repeatedly reported, with only presumptive 
connections11. A classic article, published in 1968 by Hussar 
and Pachter, had already described two incidents suffered by 
one patient: a myocardial infarction during his first ECT and 
a fatal coronary insufficiency during his second ECT, three 
months later11. Nevertheless, although these two incidents 
together strongly suggest that ECT may trigger coronary 
death in persons with significant coronary heart disease, 
to the best of our knowledge, there are no case reports, or 
any further studies with other designs, focusing specifically 
on the possible association of unstable angina and ECT in 
patients with asymptomatic coronary heart disease. Even 
among the elderly population, an age group in which more 
cardiac complications succeeding ECT can be expected, 
the statement that it does occur is still controversial, due to 
sparse research on this important topic3. There is no con-
sensus regarding guidelines for ECT pre-evaluation3,12, and, 
although there are no absolute contraindications for the 
procedure, some case reports describe fatal outcomes due 
to other ECT cardiac complications and it is known that both 
hypertension and preexisting cardiac diseases may increase 
their risk2-7,13. One possible complication of ECT is Takotsubo 
cardiomyopathy, a transient left-ventricular dysfunction that 
may occur after a physical stressor and which may increase 
the risk of myocardial infarction14. 
We believe that the clinical relevance represented by this 
report, with a potentially lethal prognosis if not adequately 
handled, indicates the need for deepening the knowledge 
of similar situations, aiming at an improvement in care and 
in the quality of future protocols. This case report illustrates 
the importance of careful workup of cardiovascular risk in the 
setting of ECT, even if electrocardiogram seems unremark-
able normal. Although it is not yet an established concept, 
we suggest that for those individuals classified as intermedi-
ate to high risk a more detailed evaluation should be used 
including treadmill exercise test and echocardiogram. It has 
been reported that ECT induces an increase in the heart rate 
reaching a peak of 140 to 180 bpm with negligible differen-
ces due to age or gender15. By inference, it would be accept-
able to verify the safety of this heart rate increase by exercise 
testing before ECT. Individuals who demonstrate uneventful 
test and normal cardiac function would be thereupon sub-
mitted to ECT and all the others would be recommended to 
reconsider using ECT as the last possible resource. It is our 
opinion that decisions in such high risk individuals must be 
shared by psychiatrist, cardiologist and patient’s family alto-
gether.  
Although the level of evidence of a case report is not high, 
as the findings cannot be replicated or generalized, the situ-
ation here described highlights the need for deepening the 
research on this matter. Other study designs, with controlled 
and randomized samples, would provide more information 
in order to establish specific protocols for ECT pre-evaluation 
among the population of elderly people without apparent 
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risk factors. Other limitation to this study is the impossibility 
to complete at least 10 ECT sessions, but as the episode of 
unstable angina was diagnosed, it was a priority to treat this 
potentially lethal condition which was itself a relative contra-
indication to the continuity of the ECT sessions. 
CONCLUSIONS
This report aims to reinforce ECT’s security and efficacy. The 
risk-benefit of indicating ECT for old-aged psychiatric pa-
tients with clinical comorbidities must be carefully evalua-
ted, possibly with complementary investigations. If neces-
sary, other specialties’ evaluations shall be performed, even 
if there had been previously found only asymptomatic and 
nonspecific EKG alterations. As cardiovascular complications 
following ECT applications are the most common ones, we 
suggest that a throughout cardiovascular assessment should 
be performed in the elderly with previous EKG abnormalities, 
even if nonspecific, in order to detect possible incipient car-
diovascular alterations and, thus, minimize the risk associa-
ted with the procedure. 
INDIVIDUAL CONTRIBUTIONS
All authors were part of the team responsible for the patient’s 
care and have significantly contributed to the conception of 
this case report. All authors carried out the literature review 
and the writing of the manuscript, critically reviewing its in-
tellectual content. All authors have read the manuscript’s fi-
nal version and have agreed with it.
CONFLICTS OF INTEREST
The authors declare no conflicts of interest and this report 
had no financial or any other funding sources.
ACKNOWLEDGEMENTS
To Claudio Eduardo Muller Banzato, for guiding the writing 
process and supervising the research group. 
REFERENCES
1.  Alonso J. Burden of mental disorders based on the World Mental Health surveys. Rev Bras 
Psiquiatr. 2012;34(1):7-8.
2.  Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, et al. Preva-
lence, severity, and unmet need for treatment of mental disorders in the World Health 
Organization World Mental Health Surveys. JAMA. 2004;291(21):2581-90.
3.  Evans DL, Staab JP, Petitto JM, Morrison MF, Szuba MP, Ward HE, et al. Depression in the 
medical setting: biopsychological interactions and treatment considerations. J Clin Psy-
chiatry. 1999;60 Suppl 4:40-55; discussion 56.
4.  Burke WJ, Rutherford JL, Zorumski CF, Reich T. Electroconvulsive therapy and the elderly. 
Compr Psychiatry. 1985;26(5):480-6. 
5.  Messina AG, Paranicas M, Katz B, Markowitz J, Yao FS, Devereux RB. Effect of elec-
troconvulsive therapy on the electrocardiogram and echocardiogram. Anesth Analg. 
1992;75(4):511-4. 
6.  Sundsted KK, Burton MC, Shah R, Lapid MI. Preanesthesia medical evaluation for electro-
convulsive therapy: a review of the literature. J ECT. 2014;30(1):35-42. 
7.  Rice EH, Sombrotto LB, Markowitz JC, Leon AC. Cardiovascular morbidity in high-risk pa-
tients during ECT. Am J Psychiatry. 1994;151(11):1637-41. 
8.  Zielinski RJ, Roose SP, Devanand DP, Woodring S, Sackeim HA. Cardiovascular complications 
of ECT in depressed patients with cardiac disease. Am J Psychiatry. 1993;150(6):904-9. 
9.  Casey DA, Davis MH. Electroconvulsive therapy in the very old. Gen Hosp Psychiatry. 
1996;18(6):436-9. 
10.  Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S, et al. Resistance 
to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry. 
1996;153(8):985-92. 
11.  Hussar AE, Pachter M. Myocardial infarction and fatal coronary insufficiency during elec-
troconvulsive therapy. JAMA. 1968;204(11):1004-7. 
12.  Martin BA, Delva NJ, Graf P, Gosselin C, Enns MW, Gilron I, et al. Delivery of electrocon-
vulsive therapy in Canada: a first national survey report on usage, treatment practice, and 
facilities. J ECT. 2015;31(2):119-24. 
13.  Lazaro JC, Dantas CR. Electroconvulsive therapy and anticoagulation after pulmonary em-
bolism: a case report. J Bras Psiquiatr. 2014;63(2):182-4.
14.  Kent LK, Weston CA, Heyer EJ, Sherman W, Prudic J. Successful retrial of ECT two months 
after ECT-induced takotsubo cardiomyopathy. Am J Psychiatry. 2009;166(8):857-62. 
15.  Swartz CM, Shen WW. Treadmill stress test maximum. J ECT. 2007;23(2):71-4. 
